Multicenter study led by NCCC shows vastly improved turnaround time to get results from the lab to the oncologist using the newest technology in the cancer testing space.
Health system laying important groundwork to begin process of recovery for benefit of patients
Joanne Conroy, MD, Visits the Medical Intensive Care Unit at Dartmouth-Hitchcock Medical Center
Dartmouth researchers have created an AI model to classify colorectal polyps on histology slides. Evaluation using 238 slides from 24 institutions across 13 US states finds that the model performs as well as practicing pathologists.
A common anti-diabetes drug being tested in many clinical trials as an anti-cancer agent activated fat metabolism that promoted the survival of dormant breast cancer cells, suggesting that the drug has context-dependent effects on cancer cells.
Steven Leach, MD, Director of Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) shares the special precautions the clinicians and staff at NCCC have taken to help ensure the safety of patients during the COVID-19 crisis.
Learn about the precautions clinicians and staff at NCCC have taken to ensure the safety of patients.
An internationally collaborative group of Dartmouth and Honduran researchers and oncologists found a high level of compliance with referral to clinical follow-up among rural Honduran women and men attending cancer screening events.
Using specialty cameras and an oxygen probe drug injection, researchers at Dartmouth’s Norris Cotton Cancer Center can now image oxygen from within cancer tumors during radiation while the probe is excited by Cherenkov light, a byproduct of radiation.
A research team led by Dartmouth’s Norris Cotton Cancer Center learns how a certain immune checkpoint inhibitor molecule acts like “brakes,” quieting the immune system from responding to cancer.